New Biotic
RaphaLX™ Trial Process News Get Updates More info
New Biotic ALS
RaphaLX™Trial ProcessNews About New Biotic ALS Get UpdatesMore info
New Biotic

Industry News

Parkinson’s Disease Linked to Gut Microbiome

Scientists have discovered for the first time a functional link between bacteria in the intestines and Parkinson’s disease (PD).

Read More
David LeighMarch 27, 2017Microbiome, Parkingson's
Rebalancing gut microbiome lengthens survival in mouse model of ALS

A bacterial by-product known to be important in maintaining gut health may slow the progression of amyotrophic lateral sclerosis, or ALS -- a progressive, neurodegenerative disease.

Read More
MicrobiomeNew BioticJanuary 9, 2017Microbiome
Glutamate Research Could Lead to ALS Treatment

Scientists believe excessive exposure to glutamate may be one of the reasons that nerve cells (motor neurons) die in ALS.

Read More
David LeighSeptember 25, 2013Glutamate Toxicity
 

If You Are Interested In Learning More About THE RaphaLX™ CLINICAL TRIAL, Sign Up To Receive Updates.

Sign Up

Biotherapeutics For Neurological Disorders

NEW BIOTIC
ABOUT
INVESTING
CAREERS
CONTACT

RAPHALX™
ABOUT
TRIAL PROCESS
FAQ

PIPELINE
NEWS
DISCLAIMER
PRIVACY POLICY

NEW BIOTIC, INC.

17875 VON KARMAN AVE., STE 150
IRVINE, CA 92614, USA
TEL: +1-949-556-8739
FAX: +1-949-556-8701
ENQUIRIES@NEWBIOTIC.COM

Copyright 2022 | New Biotic, Inc. | All Rights Reserved | Design By

Gray Never Settle.png